Marco Moschini1, Nazareno Suardi2, Federico Pellucchi3, Lorenzo Rocchini2, Giovanni La Croce2, Umberto Capitanio2, Alberto Briganti2, Rocco Damiano4, Francesco Montorsi2, Renzo Colombo2. 1. Department of Urology, San Raffaele Scientific institute, Urological Research Institute, Milan, Italy marco.moschini87@gmail.com. 2. Department of Urology, San Raffaele Scientific institute, Urological Research Institute, Milan, Italy. 3. Department of Urology, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy. 4. Department of Urology, Magna Graecia University of Catanzaro, Doctorate Research Programm, Catanzaro, Italy.
Abstract
AIM: To investigate the impact of preoperative platelet count on pathological findings at the time of Radical Cystectomy for Bladder Cancer and postoperative cancer-specific and overall survival. PATIENTS AND METHODS: A total of 906 consecutive patients treated with Radical Cystectomy for Bladder Cancer between 1995 and 2012 at a tertiary referral Center were included in the study. Thrombocytosis was defined as >400,000 platelets/μl, in agreement with the standard assumed by the central laboratory of our Institution. Univariable and multivariable logistic regression analyses were used to investigate the impact of preoperative platelet count on pathological stage. Univariate and multivariate Cox regression analyses were also adopted to predict both cancer-specific and overall survival. RESULTS: The mean age at cystectomy was 67.25 years. The mean and median platelet counts were 242,100/μl and 227,500/μl. At a mean follow-up time of 41 months, the 2- and 5-year cancer-specific and overall survival were found to be 83.1% and 75.2% and 68.3 and 59.8%, respectively. At Univariable analysis, thrombocytosis count was significantly associated with adverse pathological disease stage (p ≤ 0.007) and lymph node invasion (p=0.05). Platelet count was significantly associated to patient survival at univariable analysis (Hazard Ratio=1.76 and 1.39 for overall survival and cancer specific survival, respectively; all p<0.05). At multivariate Cox regression analysis, platelet count was documented to be significantly related only to overall survival (Hazard Ratio=64,1.03-2.81; p=0.05). CONCLUSION: Preoperative platelet count should be taken into account as a factor predictive of postoperative oncological outcomes after radical cystectomy for bladder cancer and patients should be counseled accordingly. Copyright
AIM: To investigate the impact of preoperative platelet count on pathological findings at the time of Radical Cystectomy for Bladder Cancer and postoperative cancer-specific and overall survival. PATIENTS AND METHODS: A total of 906 consecutive patients treated with Radical Cystectomy for Bladder Cancer between 1995 and 2012 at a tertiary referral Center were included in the study. Thrombocytosis was defined as >400,000 platelets/μl, in agreement with the standard assumed by the central laboratory of our Institution. Univariable and multivariable logistic regression analyses were used to investigate the impact of preoperative platelet count on pathological stage. Univariate and multivariate Cox regression analyses were also adopted to predict both cancer-specific and overall survival. RESULTS: The mean age at cystectomy was 67.25 years. The mean and median platelet counts were 242,100/μl and 227,500/μl. At a mean follow-up time of 41 months, the 2- and 5-year cancer-specific and overall survival were found to be 83.1% and 75.2% and 68.3 and 59.8%, respectively. At Univariable analysis, thrombocytosis count was significantly associated with adverse pathological disease stage (p ≤ 0.007) and lymph node invasion (p=0.05). Platelet count was significantly associated to patient survival at univariable analysis (Hazard Ratio=1.76 and 1.39 for overall survival and cancer specific survival, respectively; all p<0.05). At multivariate Cox regression analysis, platelet count was documented to be significantly related only to overall survival (Hazard Ratio=64,1.03-2.81; p=0.05). CONCLUSION: Preoperative platelet count should be taken into account as a factor predictive of postoperative oncological outcomes after radical cystectomy for bladder cancer and patients should be counseled accordingly. Copyright
Authors: Christian Niedworok; Bettina Dörrenhaus; Frank Vom Dorp; Jarowit Adam Piotrowski; Stephan Tschirdewahn; Tibor Szarvas; Herbert Rübben; Marcus Schenck Journal: World J Urol Date: 2014-11-30 Impact factor: 4.226
Authors: Mohamad Abou Chakra; David Azoulai; Mohamad Moussa; Khadija Ismail; Michael Peyromaure; Nicolas Barry Delongchamps; Djillali Saighi; Hugo Bailly; Igor Duquesne Journal: Int Urol Nephrol Date: 2022-08-25 Impact factor: 2.266
Authors: Bimal Bhindi; Thomas Hermanns; Yanliang Wei; Julie Yu; Patrick O Richard; Marian S Wettstein; Arnoud Templeton; Kathy Li; Srikala S Sridhar; Michael A S Jewett; Neil E Fleshner; Alexandre R Zlotta; Girish S Kulkarni Journal: Br J Cancer Date: 2015-12-10 Impact factor: 7.640
Authors: Andrea Mari; Riccardo Campi; Riccardo Tellini; Giorgio Gandaglia; Simone Albisinni; Mohammad Abufaraj; Georgios Hatzichristodoulou; Francesco Montorsi; Roland van Velthoven; Marco Carini; Andrea Minervini; Shahrokh F Shariat Journal: World J Urol Date: 2017-11-16 Impact factor: 4.226
Authors: Claire K S Meikle; Clare A Kelly; Priyanka Garg; Leah M Wuescher; Ramadan A Ali; Randall G Worth Journal: Front Cell Dev Biol Date: 2017-01-05